Co-Diagnostics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Co-Diagnostics, Inc. (CODX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $114.47 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2021-05-13
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-03-31 was $114.47K, a 31.76% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-12-31 was -$15.61K, a 105.59% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-09-30 was -$2.51M.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-06-30 was $2.36M, a 1476.40% increase year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $6.46K, a 97.79% decline from fiscal 2019.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2019 was $292.46K.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2018 was -$900.67K, a 228.96% decline from fiscal 2017.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2017 was $698.39K, a 4623.63% increase from fiscal 2016.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | $114.47K 10-Q · filed 2021-05-13 | $98.86K derived: sum of 2 quarters · filed 2021-05-13 | -$2.41M derived: sum of 3 quarters · filed 2021-05-13 | -$46.83K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-12-31 | -$15.61K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$2.52M derived: sum of 2 quarters · filed 2021-03-25 | -$161.30K derived: sum of 3 quarters · filed 2021-03-25 | $6.46K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$2.51M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | -$145.69K derived: sum of 2 quarters · filed 2020-11-16 | $22.08K 10-Q · filed 2020-11-16 | $301.55K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-06-30 | $2.36M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $2.53M 10-Q/A · filed 2020-11-03 | $158.61K 10-Q · filed 2020-08-13 | $2.81M derived: sum of 3 quarters · filed 2021-05-13 | $2.64M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2020-03-31 | $167.76K 10-Q · filed 2021-05-13 | $136.76K 10-Q · filed 2020-05-14 | $447.23K derived: sum of 2 quarters · filed 2021-05-13 | $276.78K derived: sum of 3 quarters · filed 2021-05-13 | $426.50K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $279.47K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $109.02K derived: sum of 2 quarters · filed 2021-03-25 | $258.74K derived: sum of 3 quarters · filed 2021-03-25 | $292.46K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$170.45K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | -$20.73K derived: sum of 2 quarters · filed 2020-11-16 | $12.99K 10-Q · filed 2020-11-16 | -$193.64K derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $149.72K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $183.45K 10-Q/A · filed 2020-11-03 | -$23.18K derived: sum of 3 quarters · filed 2020-11-03 | -$60.38K derived: sum of 4 quarters · filed 2020-11-03 | |||
| 2019-03-31 | $33.72K 10-Q · filed 2020-05-14 | -$172.91K derived: sum of 2 quarters · filed 2020-05-14 | -$210.10K derived: sum of 3 quarters · filed 2020-05-14 | -$562.06K derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$206.63K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$243.82K derived: sum of 2 quarters · filed 2020-03-30 | -$595.79K derived: sum of 3 quarters · filed 2020-03-30 | -$900.67K 10-K · filed 2020-03-30 | |||
| 2018-09-30 | -$37.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$389.16K derived: sum of 2 quarters · filed 2019-11-12 | -$694.04K 10-Q · filed 2019-11-12 | -$109.93K derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$351.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$656.85K 10-Q · filed 2019-08-14 | -$72.73K derived: sum of 3 quarters · filed 2019-08-14 | -$56.79K derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$304.88K 10-Q · filed 2019-05-14 | $279.23K derived: sum of 2 quarters · filed 2019-05-14 | $295.18K derived: sum of 3 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $584.11K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $600.06K derived: sum of 2 quarters · filed 2019-04-01 | $698.39K 10-K · filed 2019-04-01 | -$698.39K 10-K · filed 2018-03-28 | |||
| 2017-09-30 | $15.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $114.28K 10-Q · filed 2017-11-14 | |||||
| 2017-06-30 | $98.33K 10-Q · filed 2017-08-25 | ||||||
| 2016-12-31 | -$69.10K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$43.34K derived: sum of 2 quarters · filed 2018-03-28 | $14.79K 10-K · filed 2018-03-28 | ||||
| 2016-09-30 | $25.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $83.89K 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | $58.12K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |